Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort

Atherosclerosis

Volumn 241, Issue 1, 2014, Pages 271-277

  Yadav, Dhananjay ^a   Lee, Eun Soo ^a   Kim, Hong Min ^a   Choi, Eunhee ^a   Lee, Eun Young ^b   Lim, Jung Soo ^a   Ahn, Song Vogue ^a   Koh, Sang Baek ^a   Chung, Choon Hee ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Hyperuricemia; Korean adults; Metabolic syndrome; Serum uric acid

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID; BIOLOGICAL MARKER; LIPID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; FEMALE; FOLLOW UP; HUMAN; HYPERURICEMIA; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RURAL POPULATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; HEALTH; HEALTH DISPARITY; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SOUTH KOREA; TIME FACTOR;

ADULT; AGED; BIOMARKERS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS DISPARITIES; HUMANS; HYPERURICEMIA; INCIDENCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; RURAL HEALTH; SEX FACTORS; TIME FACTORS; URIC ACID; WAIST CIRCUMFERENCE;

EID: 84945397336     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.04.797     Document Type: Article

References (35)

1. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
2. Mottillo S., Filion K.B., Genest J., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 56:1113-1132.
3. Sattar N., McConnachie A., Shaper A.G., et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? outcome data from two prospective studies. Lancet 2008, 371:1927-1935.
4. Lim S., Shin H., Song J.H., et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011, 34:1323-1328.
5. Sui X., Church T.S., Meriwether R.A., et al. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008, 57:845-852.
6. Liu P.W., Chang T.Y., Chen J.D. Serum uric acid and metabolic syndrome in Taiwanese adults. Metabolism 2010, 59:802-807.
7. Lohsoonthorn V., Dhanamun B., Williams M.A. Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch. Med. Res. 2006, 37:883-889.
8. Onat A., Uyarel H., Hergenc G., et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am. J. Hypertens. 2006, 19:1055-1062.
9. Choi H.K., Ford E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am. J. Med. 2007, 120:442-447.
10. Chiou W.K., Wang M.H., Huang D.H., et al. The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J. Epidemiol. 2010, 20:219-224.
11. Yang T., Chu C.H., Bai C.H., et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 2012, 220:525-531.
12. Zhang M.L., Gao Y.X., Wang X., et al. Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults. J. Clin. Biochem. Nutr. 2013, 52:38-42.
13. Niskanen L.K., Laaksonen D.E., Nyyssonen K., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch. Intern Med. 2004, 164:1546-1551.
14. Koh S.B., Park J.K., Yoon J.H., et al. Preliminary report: a serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population. Metabolism 2010, 59:333-337.
15. Koh S.B., Yoon J., Kim J.Y., et al. Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: ARIRANG study. Yonsei Med. J. 2011, 52:234-241.
16. Kim J.Y., Ahn S.V., Yoon J.H., et al. Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care 2013, 36:1547-1553.
17. Tsukimori K., Yoshitomi T., Morokuma S., et al. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am. J. Hypertens. 2008, 21:1343-1346.
18. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes federation task force on epidemiology and prevention; National heart, lung, and blood Institute; American heart association; World Heart federation; International atherosclerosis society; and International association for the study of obesity. Circulation 2009, 120:1640-1645.
19. Lee S.Y., Park H.S., Kim D.J., et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res. Clin. Pract. 2007, 75:72-80.
20. Goncalves J.P., Oliveira A., Severo M., et al. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 2012, 41:450-457.
21. Hara S., Tsuji H., Ohmoto Y., et al. High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population. Metabolism 2012, 61:281-288.
22. Nakagawa T., Kang D.H., Feig D., et al. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 2006, 69:1722-1725.
23. Cook S., Hugli O., Egli M., et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med. Wkly. 2003, 133:360-363.
24. Baldwin W., McRae S., Marek G., et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011, 60:1258-1269.
25. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest 2004, 114:1752-1761.
26. Nakagawa T., Hu H., Zharikov S., et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Ren. Physiol. 2006, 290:F625-F631.
27. Bedir A., Topbas M., Tanyeri F., et al. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn. Heart J. 2003, 44:527-536.
28. Fruehwald-Schultes B., Peters A., Kern W., et al. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 1999, 48:677-680.
29. Nicholls A., Snaith M.L., Scott J.T. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br. Med. J. 1973, 1:449-451.
30. Ryu S., Song J., Choi B.Y., et al. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann. Epidemiol. 2007, 17:245-252.
31. Wang J.Y., Chen Y.L., Hsu C.H., et al. Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents. J. Pediatr. 2012, 161:753-756. e2.
32. Taniguchi Y., Hayashi T., Tsumura K., et al. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J. Hypertens. 2001, 19:1209-1215.
33. Ryu S., Chang Y., Zhang Y., et al. A cohort study of hyperuricemia in middle-aged South Korean men. Am. J. Epidemiol. 2012, 175:133-143.
34. Pencina M.J., D'Agostino R.B., D'Agostino R.B., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 2008, 27:157-172. discussion 207-12.
35. Lee Sbk Kyounghoon, Shin Myungsang, Ahn Minsoo, Kim Jang-Young, Yoo Byung-Su, Lee Seung-Hwan, Yoon Junghan, Yong Lee Tae, Yeon Ryu So, Ku Park Jong, Choe Kyung-Hoon Prevalence and sex-related characteristics of metabolic syndrome in a Korean rural cohort. Soc. Lipidol. Atheroscler. J. 2008, 18:226-238.